Home › Ewing Sarcoma › Connecticut › Hartford
Ewing Sarcoma clinical trials in Hartford, CT
3 studies for Ewing Sarcoma are looking for participants at sites in and around Hartford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
RecruitingPhase 1
- Connecticut Children's Medical Center, Hartford
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- Connecticut Children's Hospital, Hartford
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Connecticut Children's Hospital, Hartford
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Houston, TX7 studies
- Philadelphia, PA7 studies
- Memphis, TN7 studies
- Washington, DC6 studies
- Boston, MA6 studies
- Los Angeles, CA6 studies
- Aurora, CO6 studies
- Atlanta, GA5 studies
- Birmingham, AL5 studies
- Columbus, OH4 studies
- Tampa, FL4 studies
Other studies in Hartford
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer11 studies
- Major Depressive Disorder9 studies
- Cancer (all types)9 studies
- Breast Cancer9 studies
- Neuroblastoma8 studies
- Multiple Myeloma7 studies
- Pancreatic Cancer7 studies
- Prostate Cancer7 studies
- Ovarian Cancer7 studies
- Cardiovascular Disease7 studies
- Heart Failure7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.